Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
The company reported “absolutely zero issues” selling pre-flight Neutron missions at their full $50 million to $55 million price.
A number of stocks jumped in the afternoon session after the July jobs report showed an unexpected loss of 23,000 jobs, signaling a cooling labor market. Economists had forecast a gain of around 80,000 nonfarm payrolls.
The rocket launch and satellite specialist is growing at an impressive pace.
Combined with deals signed since Q2 closed, Rocket Lab has already booked more than $1 billion in new launch and space systems contracts, the firm said.
Rocket Lab Corporation (RKLB) delivered earnings and revenue surprises of 0.00% and +1.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Investing.com -- Rocket Lab Corp (NASDAQ:RKLB) reported second quarter results that missed earnings expectations despite posting record revenue, with shares falling 1.6% in after-hours trading Monday.
Aerospace and defense company Rocket Lab (NASDAQ:RKLB) announced better-than-expected revenue in Q2 CY2026, with sales up 62% year on year to $234.1 million. On top of that, next quarter’s revenue guidance ($257.5 million at the midpoint) was surprisingly good and 7% above what analysts were expecting. Its GAAP loss of $0.08 per share was in line with analysts’ consensus estimates.
The launch and space systems company narrowed its loss and reported rising revenue as it ended its second quarter with a backlog of $2.36 billion, up 137% year-over-year.
Shares of the SpaceX rival have risen nearly 80% over the past year on higher revenue and a growing backlog of orders.
Rocket Lab Corp. (NASDAQ:RKLB) reports second-quarter earnings Monday after the close, with investors listening for an update on Neutron. Prediction market traders are overwhelmingly skeptical the company’s next-generation rocket flies this year. Traders on Kalshi assign just a 14% probability...
Rocket Lab has shed nearly half its value from its 52-week high, and a dense stack of defense contracts and a make-or-break rocket debut are colliding at exactly the moment insiders are heading for the exits.
SpaceX stock recovered from a post-earnings selloff, trading around $135 on Monday. AST SpaceMobile was trading around $69 ahead of earnings.
On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from SpaceX last week. - Moderna (MRNA) shares are moving after last week's news that its mRNA flu shot won US approval in an FDA turnaround. - Intel (INTC) shares are moving after the company said it will be offering $15 billion in common stock, taking advantage of renewed interest in its business prospects during the artificial intelligence data center boom.
Rocket Lab stock rose slightly ahead of its earnings report on Monday. Shares rallied 27% last week.
Rocket Lab heads into today's Q2 earnings with four tailwinds—an impressive launch track record, new Space Force contracts, an $8 billion acquisition, and strong sector-wide demand signals from SpaceX's debut report.
Rocket Lab (NasdaqGS: RKLB) completed its 13th Electron launch for iQPS, further expanding the QPS-SAR Earth-imaging constellation. The mission cements Rocket Lab as the primary launch provider for iQPS, with more than eight QPS-SAR satellites now deployed via Electron. iQPS has committed to 10 additional exclusive Electron launches with Rocket Lab through the end of the decade, adding visibility to the company’s future launch pipeline. Rocket Lab is far from the only stock tied to the...
Rocket Lab just ripped 27% in a single week and has a packed August catalyst stack, while SpaceX trades on a scale narrative with almost no near-term triggers. These two space names are playing completely different games right now.
Rocket Lab's revenue continues surging to record highs, while the stock is down.
This week is much more sedate on the earnings front after a busy few weeks, which could be a good or a bad thing depending on your approach. This week we have Cisco Systems, RocketLab, CoreWeave and Applied Materials as the main companies reporting.
Rocket Lab stock has been highly volatile, but the company has kept securing new contract wins.
↗️ Berkshire Hathaway (BRK.B): The company said its quarterly profit more than doubled, powered by investment gains and strong results from its industrial and retail businesses. Shares ticked up in premarket trading.
Retail traders appear to be more interested in RKLB. RKLB’s watcher count increased 16% over three months and 56% over a year, versus 12% and 47% for ASTS.
Monday Earnings (a.m): Barrick Mining Earnings (p.m.): Simon Property, Rocket Lab, JBS, Hims & Hers Health, Trump Media Tuesday Economic data: NFIB small-business index for July, existing home sales Earnings: Cardinal Health, Lumentum, CoreWeave, Super Micro, On Holding, Smithfield Foods Wednesday Inflation data: Consumer price index for July, 8:30 a.
A fifth straight quarterly revenue record is the bar -- and the stock climbed 9% on Friday heading into the report.
Economic news this week will include data on consumer and producer prices, existing-home sales, and small-business optimism. As earnings season winds down, we’ll see results from Simon Property, Applied Materials, Cava, and more.
Spoiler alert: Analysts may be seeing this one more clearly.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
